Home News

China Wuhan Senwayer Century Chemical Co., Ltd. company news

Certification
China Wuhan Senwayer Century Chemical Co., Ltd. certification
China Wuhan Senwayer Century Chemical Co., Ltd. certification
Customer Reviews
everything was great. friendly and understanding representative and fast shipping(compared to other items on here). my shoulder feels much stronger and healthier after only one and a half weeks.

—— Terry Smith

Superb Excellence is all I can say about this Company and its products. I will continue to buy from this company. The service is excellent and the product matches the service. Thanks for the great product and service. I will be ordering from you really soon.

—— Brant huges

Love it I’ve been using it for a long time

—— Drew

I'm Online Chat Now
Company News
Latest company news about SENWAYER NEW PRODUCTS

SENWAYER NEW PRODUCTS

[2022-10-10 09:29:20]
Wuhan Senwayer Century Chemicals have some new products for clients : JBSNF-000088 Fluorene Myristate RH-Collagen III Astressin-B Contact with us , if you have interest Read More
Latest company news about Teplizumab, an Innovative Drug that Delays Type 1 Diabetes is Approved By FDA

Teplizumab, an Innovative Drug that Delays Type 1 Diabetes is Approved By FDA

[2023-01-09 16:05:51]
Recently, the US FDA announced that it has approved the marketing of the drug Tzield (teplizumab-mzwv) injection developed by Provention Bio, which is used to delay the delay in the treatment of adults with type 1 diabetes who are currently in stage 3 and in patients with type 1 diabetes who are 8 ... Read More
Latest company news about The Overall Market Size Of Nootropics

The Overall Market Size Of Nootropics

[2023-01-06 11:52:14]
The Overall Market Size Of Nootropics 2022-11-14 The overall market size of this class of drugs is about 1.22 billion yuan. In 2002, the sales amount only increased by 5.0%, but the sales volume increased by 11.2%. Several major varieties, such as piracetam, cobaltium amide and ginkgo biloba, all ... Read More
Latest company news about Dapagliflozin Approved For Chronic Kidney Disease Indications

Dapagliflozin Approved For Chronic Kidney Disease Indications

[2022-10-17 09:49:57]
Recently, AstraZeneca's SGLT2 inhibitor "dapagliflozin tablets" received approval for a new indication for adult patients with chronic kidney disease (CKD) at risk of disease progression (regardless of whether these patients have type 2 diabetes) , to reduce the estimated risk of persistent decline ... Read More
Page 1 of 1